NINKOVIC SACHA,CROSIGNANI STEFANO,SCALES STEPHANIE ANNE,MCALPINE INDRAWAN JAMES,COLLINS MICHAEL RAYMOND,MADERNA ANDREAS,WYTHES MARTIN
申请号：
IN201717031424
公开号：
IN201717031424A
申请日:
2017.09.05
申请国别(地区):
IN
年份:
2017
代理人:
摘要：
A compound of Formula I is provided: or pharmaceutically acceptable enantiomers salts or solvates thereof. The 5 invention further relates to the use of the compounds of Formula I as TDO2 inhibitors. The invention also relates to the use of the compounds of Formula I for the treatment and/or prevention of cancer neurodegenerative disorders such as Parkinson s disease Alzheimer s disease and Huntington s disease chronic viral infections such as HCV and HIV depression and obesity. The invention also 10 relates to a process for manufacturing compounds of Formula I.
